리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 중합효소 연쇄 반응 시장은 2030년까지 131억 달러에 달할 전망
2023년에 93억 달러로 추정되는 세계의 중합효소 연쇄 반응 시장은 2023-2030년 CAGR 5.0%로 성장하며, 2030년에는 131억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 PCR 기기는 CAGR 4.9%를 기록하며, 분석 기간 종료시에는 34억 달러에 달할 것으로 예측됩니다. PCR 시약 & 소모품 부문의 성장률은 분석 기간 중 CAGR 5.0%로 추정됩니다.
미국 시장은 25억 달러로 추정·예측, 중국은 CAGR 7.6%로 성장 예측
미국의 중합효소 연쇄 반응 시장은 2023년에 25억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 29억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 7.6%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.7%와 4.4%로 예측됩니다. 유럽에서는 독일이 CAGR 2.9%로 성장할 것으로 예측됩니다.
세계의 중합효소 연쇄 반응 시장 - 주요 동향과 촉진요인 정리
중합효소 연쇄 반응 : 현대 분자생물학의 초석
중합효소 연쇄 반응(PCR)은 특정 DNA 서열을 증폭할 수있는 분자 생물학의 혁신적인 기술로 1983년Kary Mullis에 의해 개발된 PCR은 연구자들이 비교적 짧은 시간에 특정 DNA 조각을 수백만 개의 사본을 만들 수있게 해주었습니다. 이 과정은 반복적인 가열 및 냉각 사이클을 통해 DNA 이중 나선의 변성, 프라이머를 표적 서열로 어닐링하고 DNA 중합효소에 의한 프라이머의 연장을 촉진하는 과정을 거칩니다. 일반적으로 반응 혼합물에는 DNA 주형, 두 유형의 프라이머, 유리 뉴클레오티드, 완충액, 변성에 필요한 고온에 견딜 수 있는 Taq 중합효소와 같은 내열성 DNA 중합효소가 포함되어 있습니다. 이 주기적인 과정을 통해 표적 DNA 영역이 기하급수적으로 증폭되어 PCR은 유전자 연구, 진단 및 법의학에서 필수적인 툴이 됩니다.
PCR은 다양한 분야에서 어떻게 활용되고 있는가?
PCR은 DNA를 빠르고 정확하게 증폭하는 능력으로 인해 다양한 과학 및 의료 분야에서 널리 사용되고 있습니다. 의료 진단에서 PCR은 박테리아나 바이러스와 같은 병원체를 검출하고 정량화하여 HIV, 간염, COVID-19와 같은 감염성 질환을 식별하는 데 사용됩니다. 유전학 검사도 PCR의 혜택을 받아 유전성 질환과 관련된 돌연변이를 식별하고 조기 진단 및 개별화된 치료 계획을 용이하게 할 수 있습니다. 법의학 분야에서 PCR은 범죄 현장에서 채취한 미세한 DNA 샘플을 분석하는 데 매우 중요하며, 용의자와 범죄 행위를 연결하는 증거를 제공합니다. 또한 PCR은 생명공학 및 제약 산업에서 복제, 유전자 발현 분석, 유전자 변형 생물체 제작 등에 사용되는 등 생명공학 및 제약 산업에서 중요한 역할을 하고 있으며, PCR의 다양성과 정확성은 유전학에 대한 이해를 높이고 공중 보건과 안전을 개선하는 데 필수적인 기술입니다. 필수적인 기술입니다.
PCR 기술 및 응용의 현재 동향은?
분자생물학의 발전과 신속하고 정확한 유전자 분석에 대한 수요 증가에 힘입어 PCR의 기술과 응용은 지속적으로 발전하고 있습니다. 중요한 동향 중 하나는 실시간 PCR로도 알려진 정량적 PCR(qPCR)의 개발로, 실시간으로 DNA 또는 RNA를 정량화할 수 있으며, 유전자 발현 및 바이러스 양에 대한 귀중한 인사이트을 제공합니다. 디지털 PCR(dPCR)은 또 다른 혁신으로, 샘플을 수천 개의 개별 반응으로 분할하여 더 높은 정확도와 민감도를 제공하여 핵산의 절대적인 정량을 가능하게 합니다. 마이크로플루이드의 발전으로 휴대용 PCR 장비가 개발되어 자원이 제한된 환경이나 현장에서 유전자 검사를 할 수 있게 되었습니다. 또한 한 번의 반응으로 여러 표적을 증폭할 수 있는 멀티플렉스 PCR은 시간과 시약의 소비를 줄여 유전자 검사의 효율성을 높이고 있습니다. 이러한 추세는 PCR의 정확성, 효율성, 접근성을 향상시키기 위한 지속적인 노력을 반영하고 있으며, 다양한 분야에서의 적용 가능성을 넓혀가고 있습니다.
PCR 시장의 성장을 가속하는 요인은 무엇인가?
PCR 시장의 성장은 고급 유전자 분석 및 진단 툴에 대한 수요 증가를 반영하는 몇 가지 요인에 의해 주도되고 있습니다. 헬스케어 분야의 확대, 특히 감염성 질환의 확산과 조기 진단의 필요성 증가는 PCR 기술의 중요한 촉진제이며, qPCR 및 dPCR의 개발과 같은 기술 발전은 PCR의 능력과 정확성을 향상시켜 다양한 용도에서 채택을 촉진하고 있습니다. 맞춤형 의료에 대한 관심이 높아지고 치료 결정을 위한 정확한 유전자 검사에 대한 필요성이 높아지면서 시장 성장에 힘을 실어주고 있습니다. 또한 생명공학 및 제약 산업의 R&D 활동이 증가함에 따라 신약 개발 및 유전공학 분야에서 PCR에 대한 수요가 증가하고 있습니다. 법의학 및 환경 모니터링에서 PCR의 사용 증가는 시장 확대를 더욱 지원하고 있으며, PCR 기술의 혁신과 개선을 위한 지속적인 연구개발 노력은 PCR 시장의 강력한 성장을 보장하고 분자 생물학의 발전과 공중 보건 결과 개선에 있으며, PCR의 중요한 역할을 강조하고 있습니다.
조사 대상 기업의 예(총 17건)
Abbott Molecular, Inc.
Agilent Technologies, Inc.
Becton, Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
QIAGEN NV
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030
The global market for Polymerase Chain Reaction estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the PCR Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.6% CAGR
The Polymerase Chain Reaction market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized
Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology
Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.
How Is PCR Utilized Across Different Fields?
PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.
What Are the Current Trends in PCR Technology and Applications?
The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.
What Factors Are Driving the Growth in the PCR Market?
The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.
Select Competitors (Total 17 Featured) -
Abbott Molecular, Inc.
Agilent Technologies, Inc.
Becton, Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
QIAGEN NV
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Polymerase Chain Reaction - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Molecular Diagnostics Propels Market Growth
Advances in PCR Technologies and Techniques Drives Adoption
Increasing Use in Infectious Disease Detection Expands Market Opportunities
Growth in Genetic and Genomic Research Strengthens Business Case for PCR
Development of Real-Time and Digital PCR Spurs Market Expansion
Expansion of Oncology and Cancer Research Generates Demand
Increasing Focus on Personalized Medicine Accelerates Market Growth
Enhanced Sensitivity and Specificity of Modern PCR Sustains Market Demand
Rising Investments in Biotechnology Research and Development Expands Addressable Market
Technological Innovations in PCR Reagents and Consumables Strengthens Market Position
Growth in Forensic and Clinical Applications Propels Market Growth
Increasing Demand for PCR in Agricultural and Food Testing Sustains Market Expansion
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Clinical Diagnostic Labs & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Pharmaceutical & Biotechnology Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Polymerase Chain Reaction Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030